CFDE Data Portal | Search CIST1

	Label	Description
	CIST1 Gene (Entity type)	ENSG00000284797 - colon, intestine and stomach enriched 1
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE129389 0 V 3 TROPIFEXOR MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE154074 1 V 0 BLEOMYCIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE165122 0 V 1 METFORMIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

CIST1

ENSG00000284797 - colon, intestine and stomach enriched 1

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE108464 AZ-628 6 v 10 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 8 v 10 human dn

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human up

A Gene Set from LINCS

GSE129389 0 V 3 TROPIFEXOR MOUSE DN

A Gene Set from LINCS

GSE108464 AZ-628 11 v 0 human dn

A Gene Set from LINCS

GSE154074 1 V 0 BLEOMYCIN MOUSE DN

A Gene Set from LINCS

GSE159678 hydroxychloroquine 6 v 7 human up

A Gene Set from LINCS

GSE165122 0 V 1 METFORMIN MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.